Evidence map›Paper›PMID 38451083›Full record

ArticleJournal of virology2024

Histone H2A variant H2A.B is enriched in transcriptionally active and replicating HSV-1 lytic chromatin.

Esteban Flores Cortes, Sarah M Saddoris, Arryn K Owens, Rebecca Gibeault, Daniel P Depledge, Luis M Schang

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Esteban Flores CortesBaker Institute for Animal Health and Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.
Sarah M SaddorisBaker Institute for Animal Health and Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.
Arryn K OwensBaker Institute for Animal Health and Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.
Rebecca GibeaultDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Daniel P DepledgeInstitute of Virology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-4292-0599
Luis M SchangBaker Institute for Animal Health and Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-5789-8590
Cornell University · USUniversity of Alberta · CAMedizinische Hochschule Hannover · DE

Funding

Chromatin dynamics in the regulation of herpes simplex virus 1 gene expression.R01AI153396 · NIAID · CORNELL UNIVERSITY · PI SCHANG, LUIS M. · 2020 to 2024
$1.9M
NIAID NIH HHS R01 AI153396
6 · The paper itself

Abstract

Herpes simplex virus 1 (HSV-1) transcription is restricted in latently infected neurons and the genomes are in mostly silenced chromatin, whereas all viral genes are transcribed in lytically infected cells, in which the genomes are dynamically chromatinized. Epigenetic regulation modulates HSV-1 transcription during lytic, latent, and reactivating infections but the precise mechanisms are not fully defined. Nucleosomes are dynamic: they slide, breathe, assemble, and disassemble. We and others have proposed that the most dynamic HSV-1 chromatin is transcriptionally competent, whereas the least dynamic is silenced. However, the mechanisms yielding the unusually dynamic viral chromatin remain unknown. Histone variants affect nucleosome dynamics. The dynamics of H2A, H2A.X, and macroH2A were enhanced in infected cells, whereas those of H2A.B were uniquely decreased. We constructed stably transduced cells expressing tagged histone H2A, H2A.B, macroH2A, or H2B, which assembles the H2A/H2B nucleosome dimers with all H2A variants. All H2A variants, as well as ectopic and endogenous H2B were assembled into HSV-1 chromatin evenly throughout the genome but canonical H2A was relatively depleted whereas H2A.B was enriched, particularly in the most dynamic viral chromatin. When viral transcription and DNA replication were restricted, H2A.B became as depleted from the viral chromatin through the entire genome as H2A. We propose that lytic HSV-1 nucleosomes are enriched in the dynamic variant H2A.B/H2B dimers to promote HSV-1 chromatin dynamics and transcriptional competency and conclude that the dynamics of HSV-1 chromatin are determined in part by the H2A variants. IMPORTANCE: Herpes simplex virus 1 (HSV-1) transcription is epigenetically regulated during latent and lytic infections, and epigenetic inhibitors have been proposed as potential antiviral drugs to modulate latency and reactivation. However, the detailed epigenetic mechanisms of regulation of HSV-1 transcription have not been fully characterized and may differ from those regulating cellular transcription. Whereas lytic HSV-1 chromatin is unusually dynamic, latent silenced HSV-1 chromatin is not. The mechanisms resulting in the unique dynamics of the lytic chromatin remain unknown. Here we identify the enrichment of the highly dynamic histone 2A variant H2A in the most dynamic viral chromatin, which provides a mechanistic understanding of its unique dynamics. Future work to identify the mechanisms of enrichment in H2A.B on the viral chromatin may identify novel druggable epigenetic regulators that modulate HSV-1 latency and reactivation.

Indexed as

ChromatinEpigenesis, GeneticGene Expression Regulation, ViralHerpesvirus 1, HumanHistonesViral TranscriptionVirus ReplicationAnimalsGene SilencingGenetic VariationHEK293 CellsHumansNucleosomesVero CellsVirus ActivationVirus LatencyChromatinHistonesNucleosomeschromatin dynamicsH2A.Bherpes simplex virus-1histone dynamicshistone variantstranscriptional competence

Identifiers

PMID38451083
PMCPMC11019955
OpenAlexW4392562082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.